
The Difference Between Meeting DSCSA and Mastering It
Cencora's Gregg Gorniak breaks down what separates basic DSCSA compliance from using it to streamline transactions and strengthen trading partnerships.
Meeting DSCSA's letter and building genuine operational efficiency are not the same thing, according to Gregg Gorniak, vice president, manufacturer operations and data services and secure supply chain lead at Cencora. Speaking with Pharmaceutical Commerce ahead of his session at
Using drop shipments as an example, Gorniak walks through how the FDA's
Gorniak argues that going beyond compliance means partnering directly with trading partners to understand their processes and investing resources so both sides can operate efficiently, rather than treating data-sharing as a one-way obligation. He also points to an emerging use case for that same serialized data: using AI to identify patterns in EPCIS files, such as recurring issues tied to a specific warehouse, 3PL or shipment type, replacing anecdotal observations with data-backed insight.
Gorniak’s answers point to a broader shift already taking shape across the industry, from treating DSCSA data as a compliance obligation to treating it as an operational asset.




